Funding for this research was provided by:
Japan Society for the Promotion of Science (26221303, 2680258, 18H02637, 26114001, 24790376)
Japan Agency for Medical Research and Development (JP19gm5010002, JP17gm5010002, JP18gm5010002, JP20gm5010002)
GlaxoSmithKline(GSK) Japan Research Grant
Received: 6 June 2020
Accepted: 11 January 2021
First Online: 11 February 2021
: E.K.N. is an advisor to EADERM Co., Ltd. All other authors have no competing interests.